Prospective Multicenter, Clinical Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
| Sponsor: |
NIAID |
| Enrolling: |
Male and Female Patients |
| IRB Number: |
AAAS2561 |
| U.S. Govt. ID: |
NCT03734393 |
| Contact: |
Marcus Pereira, MD, MPH: 212-305-3839 / mp2323@cumc.columbia.edu |
The primary objective of this study is to determine if an HIV-infected donor liver (HIVD+) transplant is safe with regards to major transplant-related and HIV-related complications. This study will evaluate if receiving a liver transplant from an HIV-infected deceased liver donor is safe with regards to survival and major transplant-related and HIV-related complications compared to receiving a liver from an HIV-uninfected deceased liver donor (HIVD-). Those participants who have accepted a HIVD- organ will be randomized to be followed in the full study or followed in the nested observational group.
This study is closed
Investigator
Marcus Pereira, MD, MPH
| Are you 18 years of age or older? |
Yes |
No |
| Are you HIV-positive? |
Yes |
No |
| Are you eligible for a liver transplant? |
Yes |
No |